US 9884868
TGF-beta inhibitors
granted A61PA61P1/04A61P1/16
Quick answer
US patent 9884868 (TGF-beta inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61P, A61P1/04, A61P1/16, A61P11/00, A61P13/08